Blood

Vol. 146, Issue Supplement 1 Issue Supplement 1 2025
8248
Articles

Articles in this Issue

Stag2 dependent chromatin remodeling enforces the erythroid-specific Gata1 cistrome

Varun Sudunagunta, Edna Stewart, Yi Chen et al. Nov 03, 2025 pp. 968-968 10.1182/blood-2025-968

Abstract The mechanisms regulating erythropoiesis have been extensively characterized, identifying a complex network of intrinsic and extrin...

Aquired hemophilla a after covid-19 infection in an 5-week old infant

Anyka Clouden-James, Roopa Kodimyala, Jay Hudgins et al. Nov 03, 2025 pp. 1311-1311 10.1182/blood-2025-1311

Abstract Clinical Summary: We report a case of a 5 week male with acquired Hemophilia A secondary to SARS-CoV-2 infection (COVID 19). He was...

Performance and clinical utility of germline genetic testing criteria for predisposition to myeloid neoplasms in adults

Sara Torres-Esquius, Maria Gabarros-Subira, Maria Eugenia Rivero et al. Nov 03, 2025 pp. 4998-4998 10.1182/blood-2025-4998

Abstract Introduction Hereditary hematopoietic malignancies (HHMs) are increasingly recognized as clinically relevant entities due to their...

The limited impact of preexisting rheumatologic diseases on outcomes after allogeneic hematopoietic stem cell transplantation: A nationwide Propensity–Matched analysis

Noirna Tanaka, Akihito Shinohara, Shun-ichi Kimura et al. Nov 03, 2025 pp. 6051-6051 10.1182/blood-2025-6051

Abstract Background Rheumatologic diseases (RDs), including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and other connect...

A murine monoclonal antibody to integrin αIIbβ3 that inhibits protein disulfide isomerase binding to platelets and platelet aggregation

Lu Wang, Jialing WANG, Jihong Li et al. Nov 03, 2025 pp. 3016-3016 10.1182/blood-2025-3016

Abstract L.W. and J.W. contributed equally Introduction: Platelet αIIbβ3 plays a pivotal role in hemostasis and thrombos...

Quantitative clinical pharmacology analysis to support the dose escalation of elranatamab + nirogacestat in the MagnetisMM-4 study

Sibo Jiang, Kamrine Poels, Melissa O'Gorman et al. Nov 03, 2025 pp. 4056-4056 10.1182/blood-2025-4056

Abstract Background Elranatamab (ELRA) is a bispecific antibody (BsAb) targeting B-cell maturation antigen (BCMA) on myeloma cells and CD3 on...

Dissecting the biology of hairy cell leukemia variant: Insights from whole exome and RNA sequencing

Antonia-Zoe Kouroutzidou, Anastasia Anastasiadou, Nikolaos Pechlivanis et al. Nov 03, 2025 pp. 5306-5306 10.1182/blood-2025-5306

Abstract Introduction: Hairy cell leukemia variant (HCL-v) is a rare aggressive splenic B-cell lymphoma that differs significantly from its...

Flumatinib versus nilotinib as first-line therapy for chronic myeloid leukemia in chronic Phase: A propensity score-matched cohort study

Ziyu Wen, Bingyu Lin, Qiang Wang et al. Nov 03, 2025 pp. 3776-3776 10.1182/blood-2025-3776

Abstract Background Flumatinib, the first China-developed second-generation tyrosine kinase inhibitor (TKI), shares structural similarities w...

Outcomes for allogeneic transplant in myelofibrosis remain suboptimal in the modern era despite increased use of post-transplant cyclophosphamide and pre-transplant JAK inhibition.

Scott Solomon, Joseph Maakaron, Lizamarie Bachier-Rodriguez et al. Nov 03, 2025 pp. 7830-7830 10.1182/blood-2025-7830

Abstract Allogeneic transplant remains the only curative therapy for patients with primary or secondary myelofibrosis (MF), but outcomes rem...

Developing prediction rules to safely decrease unnecessary head CT scans for pediatric patients with hemophilia presenting with head injuries

Lylie Hinh, Rachel Bailey, Gita Massey et al. Nov 03, 2025 pp. 536-536 10.1182/blood-2025-536

Abstract BACKGROUND: Guidelines for managing head injury in pediatric patients with hemophilia (PwH) are limited. The National Bleeding Diso...

Development of a novel CD19/BCMA dual CAR-T for autoimmune diseases

Yongwei Zheng, Lisen Luo, Wen Ding et al. Nov 03, 2025 pp. 7639-7639 10.1182/blood-2025-7639

Abstract CD19 and BCMA CAR-T therapies have recently gained widespread application in the field of autoimmune diseases, demonstrating remark...

Efficient prime editing of human hematopoietic stem cells corrects the recurrent SBDS C.258+2T>C mutation and recovers engraftment potential in shwachman-diamond syndrome

Gue-Ho Hwang, Michael Peters, Felicia Andresen et al. Nov 03, 2025 pp. 1063-1063 10.1182/blood-2025-1063

Abstract Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure disorder associated with myelodysplastic syndrome and acute my...

Multi-dimensional adherence patterns in rare haematological conditions: Longitudinal analysis of real-world patient-reported outcomes

Kim Summers, Orlando Agrippa, Andrea Preston et al. Nov 03, 2025 pp. 7973-7973 10.1182/blood-2025-7973

Abstract Background Capturing longitudinal patient-reported outcomes (PROs) beyond healthcare visits is central to understanding real-world...

We're not talking about sex: Hematopoietic stem cell transplant provider practices and barriers to sexual health discussions with adolescents and young adults

Brittany Kimball, Mira Kohorst, Asmaa Ferdjallah et al. Nov 03, 2025 pp. 2872-2872 10.1182/blood-2025-2872

Abstract Introduction: Sexual health is an important part of overall well-being for adolescents and young adults (AYAs) after hematopoietic...

A predictive model for treatment failure in CLL/SLL patients receiving BTK inhibitor: A multi-center retrospective study

Yutang Li, Xinting Hu, Yupiao Feng et al. Nov 03, 2025 pp. 7423-7423 10.1182/blood-2025-7423

Abstract Background: Despite the significant improvement in outcomes for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) p...

Closing the gap in vaso-occlusive episode triage for sickle cell patients: A quality improvement initiative

Saumya Easaw, Christopher Griggs, Juliann Meckola et al. Nov 03, 2025 pp. 6154-6154 10.1182/blood-2025-6154

Abstract Introduction: Painful vaso-occlusive episodes (VOE) are the most common complication prompting emergency care in patients with sick...

Oncogenic ASPP2κ: A novel regulator of drug resistance and tumor progression in multiple myeloma

Marcus Schittenhelm, Reka Haraszti, Christoph Driessen et al. Nov 03, 2025 pp. 5729-5729 10.1182/blood-2025-5729

Abstract Treatment options for multiple myeloma (MM) have improved significantly in recent years. Nevertheless, therapy resistance occurs in...

Divergent exhaustion networks define memory CD8+ T cell subset fate under chronic stimulation and reveal targets for epigenetic reprogramming

Leonel Torres, Brandon Simone, Trenton Campos et al. Nov 03, 2025 pp. 4777-4777 10.1182/blood-2025-4777

Abstract T cell exhaustion (TEX) impairs the efficacy of cancer immunotherapies. Following activation from an acutely resolved infection or...

Phase II frontline chemolight R-pola-glo trial induces high and durable response rates in elderly and medically unfit/frail patients with aggressive B-cell lymphoma

Björn Chapuy, Rebecca Wurm-Kuczera, Ralph Michael et al. Nov 03, 2025 pp. 61-61 10.1182/blood-2025-61

Abstract Background Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma in adults, predominantl...

Evaluation of response assessment in chronic lymphocytic leukaemia using measurable residual disease by flow cytometry: Prospective observational study.

Karthik Jayalingappa, Bhawana Adhikari, Prisla Dalton et al. Nov 03, 2025 pp. 7438-7438 10.1182/blood-2025-7438

Abstract Background : Measurable residual disease (MRD) status has recently emerged to evaluate treatment efficacy, predict long-term outcom...

Partnering with patients to guide the development of impactful educational resources for warm autoimmune hemolytic anemia (wAIHA)

Azreen Iqbal, Zia Choudhry, Lisa Shea et al. Nov 03, 2025 pp. 2862-2862 10.1182/blood-2025-2862

Abstract Introduction: Warm autoimmune hemolytic anemia (wAIHA) is a rare, life-threatening, relapsing, autoantibody-driven disease associat...

Twenty-five-year mortality trends of aplastic and secondary anemias in diabetic adults of the United States (U.S.): A CDC wonder multiple cause of death analysis (from 1999 to 2023)

Amna Amjad, Abdullah Bin Usman, Shalin Rawal et al. Nov 03, 2025 pp. 6730-6730 10.1182/blood-2025-6730

Abstract Introduction: Aplastic anemia, characterized by bone marrow failure leading to pancytopenia. In parallel, secon...

A novel: Plasma apoptosis assay to demonstrate CLL cell target engagement in first-in-human study of a highly selective oral bcl-2 inhibitor lonitoclax (ZE50-0134)

John Byrd, Brian Ledwith, Fraser Pickersgill et al. Nov 03, 2025 pp. 6819-6819 10.1182/blood-2025-6819

Abstract Background. B-cell lymphoma 2 (Bcl-2) is a member of the anti-apoptotic Bcl-2 family. Sensitivity to pharmaceutical disruption of B...

Molecular spectrum of alpha thalassemia: An unrecognised blood disorder in Nepal

Suravi Pandey, Bishesh Sharma Poudyal, Krishna Maharjan et al. Nov 03, 2025 pp. 2912-2912 10.1182/blood-2025-2912

Abstract Background: Thalassemia and hemoglobinopathies are inherited disorders characterized by impaired hemoglobin synthesis and chronic a...

Clinical features and outcome of Philadelphia chromosome-positive acute lymphoblastic leukemia: A 15-year retrospective study

Yiyan Zhu, Wenzhi Cai, Xueqing Dou et al. Nov 03, 2025 pp. 5103-5103 10.1182/blood-2025-5103

Abstract Introduction Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is a common hematological malignancy in adults...

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page